Palbociclib

Synonym
Product Category
Product Code
CAS Number
MDL Number
Pubchem CID
Reaxys RN
PD 0332991, PD 332991
API & Intermediates
KAPI0F18
571190-30-2
MFCD11840850
5330286
10219048
image-155171-Trimethyl(trifluoromethyl)silane_reagent.png
Chemical Name
Molecular Formula
Molecular Weight
Assay
Appearance
Melting Point
Packaging
Storage
Palbociclib
C24H29N7O2
447.54
≥99.8%(HPLC)
Light Yellow to Yellow Solid
263-268°C
500mg,1g,10g,25g,50g,100g and 500g
-20°C Freezer
Palbociclib (also known as PD 0332991, PD 332991) is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6 for the treatment of ER-positive and HER2-negative breast cancer.
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. [1]
Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer. [2]
Recent advances of highly selective CDK4/6 inhibitors in breast cancer. [3]
References:
[1] R.S.Finn, et al, Breast Cancer Res., 2009, 11(5), pp R77-.
[2] A.Rocca, et al, Expert. Opin. Pharmacother., 2014, 15(3), pp 407-420.
[3] H.Xu, et al, J. Hematol. Oncol., 2017, 10, pp 97:1-12.
Signal Word
Hazard Statements
Precautionary Statements
HS Code
RIDADR
Legal Information
Warning
H315,H319,H335
P261,P264,P271,P280

NONH for all modes of transport
Sales restrictions may apply.
1. Product Specification
2. Safety Data Sheet
Available on request.
Please inquire for pricing and availability of this product by writing email to sales@kumidas.com.